Constitutive activation of dopamine receptors DRD1,[54] DRD2,[55, 56] DRD5[52, 57] has been reported in relation to development and neurological disease, but the impact of the functional change on cancer progression and metastasis remains unclear. This evidence concerns the gene DRD5 and nervous system disorder.